Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Intensification with Abacavir in HIV
NCT00001132Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 1999; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001132.